Although AI has introduced a new threat in the world of payments fraud, it has also emerged as the analytical backbone of next-generation fraud mitigation systems.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.